Guest guest Posted April 19, 2002 Report Share Posted April 19, 2002 I did a little research on CGRP antagonists on the web. I didnt find a whole lot, but I found this website at the U.S. patent office or something. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/\ netahtml/srchnum.htm&r=1&f=G&l=50&s1='5932215'.WKU.&OS=PN/5932215&RS=PN/5932215 Not sure if the link will work. Anyway, it talks about CGRP has been shown in studies to be effective for treating cea and erythema for many of the reasons that have already been discussed on here. It talks about how cea has no cure, and how products like Metronidazole, antibiotics, etc, are primarily ineffective at treating certain aspects of cea because they dont go after the cause of the disorder. This patent talks about a topical CGRP-blocker, possibly mixed with a substance-P blocker, or antiinflammatory substances, or even with antibiotics. It seems like something that was actually put together like this would blow every other cea treatment currently available right out of the water. At the end they give seven examples of how to make a succesful CGRP-blocking topical: " EXAMPLE 1 Face cream (oil-in-water emulsion): ______________________________________ CGRP 8-37 0.5% Glyceryl stearate 2% Polysorbate 60 (Tween 60 1% marketed by ICI) Stearic acid 1.4% Triethanolamine 0.7% Carbomer 0.4% Cyclomethicone 8% Sunflower Oil 12% Antioxidant 0.05% Preservative 0.3% Water qs 100% EXAMPLE 5 Cream (oil-in-water emulsion): ______________________________________ Glyceryl stearate 2% CGRP 8-37 0.02% Polysorbate 60 (Tween 60 1% marketed by ICI) Stearic acid 1.4% Metronidazole 0.5% Triethanolamine 0.7% Carbomer 0.4% Cyclomethicone 8% Sunflower oil 10% Antioxidant 0.05% Preservative 0.3% Water qs 100%The website made it sound like the technology already exists to make this happen, so my question is, why hasnt it happened yet?Adam Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 >...The website made it sound like the technology already exists to > make this happen, so my question is, why hasnt it happened yet? Adam, narratives and formulations in this context are related to gaining a patent. I didn't visit the site but from what I know, securing a patent to an ingredient is one of the first, not one of the last, steps in manufacturing and distributing a product. If it's a drug, it also needs to be FDA approved, which is years of studies for safety and efficacy. Marjorie Marjorie Lazoff, MD > I did a little research on CGRP antagonists on the web. I didnt find a whole lot, but I found this website at the U.S. patent office or something. > > http://patft.uspto.gov/netacgi/nph-Parser? Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/srchnum.htm&r=1&f=G&l=5 0&s1='5932215'.WKU.&OS=PN/5932215&RS=PN/5932215 > > Not sure if the link will work. Anyway, it talks about CGRP has been shown in studies to be effective for treating cea and erythema for many of the reasons that have already been discussed on here. It talks about how cea has no cure, and how products like Metronidazole, antibiotics, etc, are primarily ineffective at treating certain aspects of cea because they dont go after the cause of the disorder. This patent talks about a topical CGRP- blocker, possibly mixed with a substance-P blocker, or antiinflammatory substances, or even with antibiotics. It seems like something that was actually put together like this would blow every other cea treatment currently available right out of the water. At the end they give seven examples of how to make a succesful CGRP- blocking topical: > > " EXAMPLE 1 > > Face cream (oil-in-water emulsion): > > > ______________________________________ > CGRP 8-37 0.5% > Glyceryl stearate 2% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower Oil 12% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100% > > EXAMPLE 5 Cream (oil-in-water emulsion): ______________________________________ > Glyceryl stearate 2% > CGRP 8-37 0.02% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Metronidazole 0.5% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower oil 10% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100%> > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 >...The website made it sound like the technology already exists to > make this happen, so my question is, why hasnt it happened yet? Adam, narratives and formulations in this context are related to gaining a patent. I didn't visit the site but from what I know, securing a patent to an ingredient is one of the first, not one of the last, steps in manufacturing and distributing a product. If it's a drug, it also needs to be FDA approved, which is years of studies for safety and efficacy. Marjorie Marjorie Lazoff, MD > I did a little research on CGRP antagonists on the web. I didnt find a whole lot, but I found this website at the U.S. patent office or something. > > http://patft.uspto.gov/netacgi/nph-Parser? Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/srchnum.htm&r=1&f=G&l=5 0&s1='5932215'.WKU.&OS=PN/5932215&RS=PN/5932215 > > Not sure if the link will work. Anyway, it talks about CGRP has been shown in studies to be effective for treating cea and erythema for many of the reasons that have already been discussed on here. It talks about how cea has no cure, and how products like Metronidazole, antibiotics, etc, are primarily ineffective at treating certain aspects of cea because they dont go after the cause of the disorder. This patent talks about a topical CGRP- blocker, possibly mixed with a substance-P blocker, or antiinflammatory substances, or even with antibiotics. It seems like something that was actually put together like this would blow every other cea treatment currently available right out of the water. At the end they give seven examples of how to make a succesful CGRP- blocking topical: > > " EXAMPLE 1 > > Face cream (oil-in-water emulsion): > > > ______________________________________ > CGRP 8-37 0.5% > Glyceryl stearate 2% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower Oil 12% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100% > > EXAMPLE 5 Cream (oil-in-water emulsion): ______________________________________ > Glyceryl stearate 2% > CGRP 8-37 0.02% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Metronidazole 0.5% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower oil 10% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100%> > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 20, 2002 Report Share Posted April 20, 2002 >...The website made it sound like the technology already exists to > make this happen, so my question is, why hasnt it happened yet? Adam, narratives and formulations in this context are related to gaining a patent. I didn't visit the site but from what I know, securing a patent to an ingredient is one of the first, not one of the last, steps in manufacturing and distributing a product. If it's a drug, it also needs to be FDA approved, which is years of studies for safety and efficacy. Marjorie Marjorie Lazoff, MD > I did a little research on CGRP antagonists on the web. I didnt find a whole lot, but I found this website at the U.S. patent office or something. > > http://patft.uspto.gov/netacgi/nph-Parser? Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/srchnum.htm&r=1&f=G&l=5 0&s1='5932215'.WKU.&OS=PN/5932215&RS=PN/5932215 > > Not sure if the link will work. Anyway, it talks about CGRP has been shown in studies to be effective for treating cea and erythema for many of the reasons that have already been discussed on here. It talks about how cea has no cure, and how products like Metronidazole, antibiotics, etc, are primarily ineffective at treating certain aspects of cea because they dont go after the cause of the disorder. This patent talks about a topical CGRP- blocker, possibly mixed with a substance-P blocker, or antiinflammatory substances, or even with antibiotics. It seems like something that was actually put together like this would blow every other cea treatment currently available right out of the water. At the end they give seven examples of how to make a succesful CGRP- blocking topical: > > " EXAMPLE 1 > > Face cream (oil-in-water emulsion): > > > ______________________________________ > CGRP 8-37 0.5% > Glyceryl stearate 2% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower Oil 12% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100% > > EXAMPLE 5 Cream (oil-in-water emulsion): ______________________________________ > Glyceryl stearate 2% > CGRP 8-37 0.02% > Polysorbate 60 (Tween 60 > 1% > marketed by ICI) > Stearic acid 1.4% > Metronidazole 0.5% > Triethanolamine 0.7% > Carbomer 0.4% > Cyclomethicone 8% > Sunflower oil 10% > Antioxidant 0.05% > Preservative 0.3% > Water qs 100%> > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.